MedPath
HSA Approval

MEROPENEM-AFT POWDER FOR INJECTION 1G

SIN14858P

MEROPENEM-AFT POWDER FOR INJECTION 1G

MEROPENEM-AFT POWDER FOR INJECTION 1G

October 5, 2015

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS

Medical Information

J01DH02

meropenem

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

Shenzhen Haibin Pharmaceutical Co., Ltd

Biolab Co., Ltd.

Active Ingredients

Meropenem trihydrate eqv Meropenem

1g/vial

Meropenem

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MEROPENEM-AFT POWDER FOR INJECTION 1G - HSA Approval | MedPath